๐ŸŽ‰ ื”ืืชืจ ื‘ืฉื™ืžื•ืฉ ื—ื™ื ื ืขื“ 16.9.2026 โ€” ื ืกื• ืื•ืชื™ ืœืจื’ืœ ื”ื”ืฉืงื”!
S&P 5007,702.74โ–ผ 0.27%
ื“ืื• ื’'ื•ื ืก53,950.28โ–ผ 0.73%
ื ืืกื“"ืง26,315.13โ–ผ 0.18%
ืจืืกืœ 20003,016.3โ–ผ 0.10%
ืžื“ื“ ื”ืคื—ื“ (VIX)15.56โ–ผ 1.58%
ืช"ื 125โ‚ช4,032.47โ–ฒ 0.23%
S&P 5007,702.74โ–ผ 0.27%
ื“ืื• ื’'ื•ื ืก53,950.28โ–ผ 0.73%
ื ืืกื“"ืง26,315.13โ–ผ 0.18%
ืจืืกืœ 20003,016.3โ–ผ 0.10%
ืžื“ื“ ื”ืคื—ื“ (VIX)15.56โ–ผ 1.58%
ืช"ื 125โ‚ช4,032.47โ–ฒ 0.23%

ืžื ืชื—ื™ื ืืช ื”ืžื ื™ื”โ€ฆ

ืื•ืกืคื™ื ื ืชื•ื ื™ื ื˜ื›ื ื™ื™ื, ืคื•ื ื“ืžื ื˜ืœื™ื™ื ื•ืฉื•ืง โ€” ื›ืžื” ืฉื ื™ื•ืช

ืžื ื™ื™ืช Vanda Pharmaceuticals Inc. (VNDA) โ€” ืฆื™ื•ืŸ 31/100 | StockIQ